[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU7029000A - Spa in a screening method for modulators of glucokinase - Google Patents

Spa in a screening method for modulators of glucokinase

Info

Publication number
AU7029000A
AU7029000A AU70290/00A AU7029000A AU7029000A AU 7029000 A AU7029000 A AU 7029000A AU 70290/00 A AU70290/00 A AU 70290/00A AU 7029000 A AU7029000 A AU 7029000A AU 7029000 A AU7029000 A AU 7029000A
Authority
AU
Australia
Prior art keywords
glucokinase
spa
modulators
screening method
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70290/00A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU7029000A publication Critical patent/AU7029000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU70290/00A 1999-09-15 2000-09-13 Spa in a screening method for modulators of glucokinase Abandoned AU7029000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9921684.8A GB9921684D0 (en) 1999-09-15 1999-09-15 Assays
GB9921684 1999-09-15
PCT/GB2000/003495 WO2001020327A1 (en) 1999-09-15 2000-09-13 Spa in a screening method for modulators of glucokinase

Publications (1)

Publication Number Publication Date
AU7029000A true AU7029000A (en) 2001-04-17

Family

ID=10860872

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70290/00A Abandoned AU7029000A (en) 1999-09-15 2000-09-13 Spa in a screening method for modulators of glucokinase

Country Status (5)

Country Link
EP (1) EP1218742A1 (en)
JP (1) JP2003509070A (en)
AU (1) AU7029000A (en)
GB (1) GB9921684D0 (en)
WO (1) WO2001020327A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102299D0 (en) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (en) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
EP1835928A2 (en) * 2004-12-22 2007-09-26 Rheoscience A/S Mas related g protein coupled receptors as drug targets
RU2008112198A (en) 2005-09-29 2009-10-10 Санофи-Авентис (Fr) DERIVATIVES OF PHENYL-1,2,4-OXADIAZAZOLONE, METHODS FOR THEIR PRODUCTION AND THEIR APPLICATION AS PHARMACEUTICAL PRODUCTS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021330A1 (en) * 1992-04-22 1993-10-28 Zymogenetics, Inc. Human glutamine:fructose-6-phosphate amino-transferase
WO1998020024A1 (en) * 1996-11-04 1998-05-14 Merck Frosst Canada & Co. Ligands for phosphatase binding assay

Also Published As

Publication number Publication date
JP2003509070A (en) 2003-03-11
GB9921684D0 (en) 1999-11-17
EP1218742A1 (en) 2002-07-03
WO2001020327A1 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
AU4810800A (en) Prosthetic apparatus and method
AU7171398A (en) Apparatus for producing titanium crystal and titanium
AU2075601A (en) Sand control method and apparatus
AU6759600A (en) Thru-tubing sand control method and apparatus
AU3884901A (en) Bone fusion apparatus and method
AU3398700A (en) Assistance method and apparatus
AU1160801A (en) Apparatus and method
AU3543400A (en) Application apparatus and method
AU7484500A (en) Cargo-transfer apparatus and method
AU7600198A (en) Formation treatment method using deformable particles
AUPP855599A0 (en) Apparatus and method
AU7270898A (en) Method for producing titanium crystal and titanium
AU7845300A (en) Book and method for making a book
AU7441000A (en) A method for preparing and screening one or more compounds
AUPQ276099A0 (en) Electrophoresis apparatus and a method of using the same
AU7383600A (en) A method and system for the simplification of leaf-limited bridges
AU7029000A (en) Spa in a screening method for modulators of glucokinase
AU1772901A (en) Endarterectomy apparatus and method
AU1553101A (en) Screening method
AU6429000A (en) Screening method
AU4791900A (en) Synchronization method and apparatus
AU1366301A (en) A method and system for the simplification of leaf-limited bridges
AU2872501A (en) Screening method
AU5470400A (en) Method and apparatus for encoding bitstreams using rotation
AU3560900A (en) Method and apparatus for distributing mortar

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase